Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cystetine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 known ✓ | P41231 | 4/20 | 0.69 |
| ▸ | P2RY4 known ✓ | P51582 | 2/20 | 0.69 |
| ▸ | P2RY6 known ✓ | Q15077 | 2/20 | 0.63 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | GLA | P06280 | 1/20 | 0.81 |
| ▸ | ST6GAL1 | P15907 | 10/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MTOR | P42345 | 1/20 | 0.60 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.60 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.60 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystetine Triphosphate SCHEMBL31405617 | 0.99 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL10826769 | 0.99 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| SCHEMBL29356399 | 0.98 | TSHR (0.81) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| SCHEMBL5407898 | 0.98 | TSHR (0.81) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Potassium Ion SCHEMBL10585798 | 0.97 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL2194120 | 0.94 | TSHR (0.79) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL11613107 | 0.94 | TSHR (0.79) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL28754273 | 0.93 | TSHR (0.72) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL27792998 | 0.92 | TSHR (0.71) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| SCHEMBL11616961 | 0.92 | TSHR (0.78) | TSHRGLAST6GAL1P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115613085-A | Brush silver-plating alloy plating solution for repairing silver-plated layer of open-type isolating switch and preparation method thereof | 国网山东省电力公司电力科学研究院 | 2023-01-17 | — | — | CN | claimed |
| CN-108265094-B | Preparation method of alpha-2, 3 deaminated sialyllactulose | 河南科技学院 | 2021-03-19 | — | — | CN | claimed |
| CN-105106240-A | Novel stem cell preparation and application thereof in vascular intervention therapy of cerebral apoplexy | JIANGSU STEM CELL OSDBIO CO LTD | 2015-12-02 | — | — | CN | claimed |
| CN-104906055-A | Preparation method of cytidine disdoium triphosphate freeze-dried powder injection | HUNAN KELUN PHARMACEUTICAL CO | 2015-09-16 | — | — | CN | claimed |
| CN-102614135-B | Cytidine disodium triphosphate suspension powder injection and preparation method thereof | ZHEJIANG PANGU PHARMACEUTICAL CO LTD | 2013-08-14 | — | — | CN | claimed |
| CN-101569611-B | Lyophilized cytidine disodium triphosphate powder needle reagent for injection | HANGZHOU AOYA BIO TECH CO LTD | 2011-05-11 | — | — | CN | claimed |
| CN-101658498-A | Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof | GUANGDONG P D | 2010-03-03 | — | — | CN | claimed |
| CN-101569611-A | Lyophilized cytidine disodium triphosphate powder needle reagent for injection | HANGZHOU AOYA BIO TECH CO LTD (CN) | 2009-11-04 | — | — | CN | claimed |
| CN-101518515-A | Cytidine disodium triphosphate freeze-dried powder-injection for injection | KELUN PHARMACEUTICAL RES CO LT | 2009-09-02 | — | — | CN | claimed |
| CN-100528174-C | Combination of cytidine disodium triphosphate and arginine, and preparation method thereof | NING HUI QU HAIJUN JING FANBO (CN) | 2009-08-19 | — | — | CN | claimed |
| CN-101390873-A | Cytidine disodium triphosphate and arginine composition and preparation method thereof | HUI NING (CN) | 2009-03-25 | — | — | CN | claimed |
| CN-100370995-C | Sodium triphosphate transfusion and its prepn. technique | SHANTOU CITY JIANXIN MEDICAMEN (CN) | 2008-02-27 | — | — | CN | claimed |
| CN-1833655-A | Sodium triphosphate transfusion and its prepn. technique | JIANXIN MEDICAMENTS CO LTD SHA (CN) | 2006-09-20 | — | — | CN | claimed |
| CN-1660126-A | Medication of combination of sodium cytidine triphosphate and ebselen | YANG XIHONG (CN) | 2005-08-31 | — | — | CN | claimed |
| CN-1616104-A | Transfusion medicine prepared from xylitol as istonic regulator and various injections separately and its preparing method | CUI XIAOTING (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1579412-A | Cytidine triphosphate disodium chloride injecta and its preparation process | JIANG WEISHI (CN) | 2005-02-16 | — | — | CN | claimed |
| CN-1562345-A | Drug combination including activator for metabolism of brain and free radical scavenger | YANG XIHONG (CN) | 2005-01-12 | — | — | CN | claimed |
| CN-1557331-A | Oral prescription of cytidine triphosphate | 杨喜鸿 | 2004-12-29 | — | — | CN | claimed |
| CN-1513468-A | Compound medicine of sodium citicoline and disodium cytidine triphosphate | 杨喜鸿 | 2004-07-21 | — | — | CN | claimed |
| US-20230383287-A1 | ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF | HELIX NANOTECHNOLOGIES INC | 2023-11-30 | — | — | US | disclosed |
| WO-2023215516-A2 | ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF | HELIX NANOTECHNOLOGIES, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| CN-115613085-A | Brush silver-plating alloy plating solution for repairing silver-plated layer of open-type isolating switch and preparation method thereof | 国网山东省电力公司电力科学研究院 | 2023-01-17 | — | — | CN | disclosed |
| CN-107737339-B | Calcium phosphate-biomolecule composite material and preparation method thereof | 中国科学院上海硅酸盐研究所 | 2021-06-15 | — | — | CN | disclosed |
| CN-108265094-B | Preparation method of alpha-2, 3 deaminated sialyllactulose | 河南科技学院 | 2021-03-19 | — | — | CN | disclosed |
| CN-108265094-B | Preparation method of alpha-2, 3 deaminated sialyllactulose | 河南科技学院 | 2021-03-19 | — | — | CN | disclosed |
| US-10195226-B2 | Medicinal carbohydrates for treatment of respiratory conditions | AUSTRALIAN BIOMEDICAL COMPANY PTY LTD. (AU) | 2019-02-05 | — | — | US | disclosed |
| EP-2448590-B1 | MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS | AUSTRALIAN BIOMEDICAL COMPANY PTY LTD (AU) | 2018-10-31 | — | — | EP | disclosed |
| CN-106632531-A | Method for preparing alpha-2,3glycolyl sialic acid lactulose | 河南科技学院 | 2017-05-10 | — | — | CN | disclosed |
| CN-105949250-A | Preparation method of alpha-2,3-sialyllactulose | 河南科技学院 | 2016-09-21 | — | — | CN | disclosed |
| CN-105457035-A | Accessory for injection or oral taking | ZHONG SHUGUANG | 2016-04-06 | — | — | CN | disclosed |
| CN-105106240-A | Novel stem cell preparation and application thereof in vascular intervention therapy of cerebral apoplexy | JIANGSU STEM CELL OSDBIO CO LTD | 2015-12-02 | — | — | CN | disclosed |
| CN-105031108-A | Medicine for treating chronic amyotrophic lateral sclerosis | JIANG SHIFEN | 2015-11-11 | — | — | CN | disclosed |
| CN-104906055-A | Preparation method of cytidine disdoium triphosphate freeze-dried powder injection | HUNAN KELUN PHARMACEUTICAL CO | 2015-09-16 | — | — | CN | disclosed |
| US-20150238512-A1 | MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS | AUSTRALIAN BIOMEDICAL COMPANY PTY LTD (AU) | 2015-08-27 | — | — | US | disclosed |
| US-9040503-B2 | Medicinal carbohydrates for treatment of respiratory conditions | AUSTRALIAN BIOMEDICAL COMPANY PTY LTD. (AU) | 2015-05-26 | — | — | US | disclosed |
| CN-102614135-B | Cytidine disodium triphosphate suspension powder injection and preparation method thereof | ZHEJIANG PANGU PHARMACEUTICAL CO LTD | 2013-08-14 | — | — | CN | disclosed |
| US-20120142619-A1 | MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS | Australian Blomedical Company Pty Ltd, (AU) | 2012-06-07 | — | — | US | disclosed |
| CN-101569611-B | Lyophilized cytidine disodium triphosphate powder needle reagent for injection | HANGZHOU AOYA BIO TECH CO LTD | 2011-05-11 | — | — | CN | disclosed |
| CN-101658498-A | Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof | GUANGDONG P D | 2010-03-03 | — | — | CN | disclosed |
| CN-101569611-A | Lyophilized cytidine disodium triphosphate powder needle reagent for injection | HANGZHOU AOYA BIO TECH CO LTD (CN) | 2009-11-04 | — | — | CN | disclosed |
| CN-101518515-A | Cytidine disodium triphosphate freeze-dried powder-injection for injection | KELUN PHARMACEUTICAL RES CO LT | 2009-09-02 | — | — | CN | disclosed |
| CN-100528174-C | Combination of cytidine disodium triphosphate and arginine, and preparation method thereof | NING HUI QU HAIJUN JING FANBO (CN) | 2009-08-19 | — | — | CN | disclosed |
| CN-101390873-A | Cytidine disodium triphosphate and arginine composition and preparation method thereof | HUI NING (CN) | 2009-03-25 | — | — | CN | disclosed |
| CN-100370995-C | Sodium triphosphate transfusion and its prepn. technique | SHANTOU CITY JIANXIN MEDICAMEN (CN) | 2008-02-27 | — | — | CN | disclosed |
| CN-1833655-A | Sodium triphosphate transfusion and its prepn. technique | JIANXIN MEDICAMENTS CO LTD SHA (CN) | 2006-09-20 | — | — | CN | disclosed |
| CN-1660126-A | Medication of combination of sodium cytidine triphosphate and ebselen | YANG XIHONG (CN) | 2005-08-31 | — | — | CN | disclosed |
| CN-1660126-A | Medication of combination of sodium cytidine triphosphate and ebselen | YANG XIHONG (CN) | 2005-08-31 | — | — | CN | disclosed |
| CN-1579412-A | Cytidine triphosphate disodium chloride injecta and its preparation process | JIANG WEISHI (CN) | 2005-02-16 | — | — | CN | disclosed |
| CN-1562345-A | Drug combination including activator for metabolism of brain and free radical scavenger | YANG XIHONG (CN) | 2005-01-12 | — | — | CN | disclosed |
| CN-1557331-A | Oral prescription of cytidine triphosphate | 杨喜鸿 | 2004-12-29 | — | — | CN | disclosed |
| CN-1513468-A | Compound medicine of sodium citicoline and disodium cytidine triphosphate | 杨喜鸿 | 2004-07-21 | — | — | CN | disclosed |
| EP-0278005-A1 | DNA FOR SHUTTLE VECTOR | TAIYO KAGAKU Co., LTD. (JP) | 1988-08-17 | — | — | EP | disclosed |
| EP-0278005-A1 | DNA FOR SHUTTLE VECTOR | TAIYO KAGAKU Co., LTD. (JP) | 1988-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230383287-A1 | ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF | NSUN2, NSUN3, ADAR | P2RY2 3581/4885P2RY4 3754/4885P2RY6 3557/4885 |
| US-20150238512-A1 | MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS | FUT6, NEU3, FUT5 | P2RY2 4012/4885P2RY4 3796/4885P2RY6 3285/4885 |
| US-20120142619-A1 | MEDICINAL CARBOHYDRATES FOR TREATMENT OF RESPIRATORY CONDITIONS | FUT6, ST6GAL1, FUT5 | P2RY2 2729/4885P2RY4 2374/4885P2RY6 2539/4885 |
| US-10195226-B2 | Medicinal carbohydrates for treatment of respiratory conditions | FUT6, NEU3, FUT5 | P2RY2 4012/4885P2RY4 3796/4885P2RY6 3285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.